Triple therapy aims to slow kidney disease in teens
NCT ID NCT07483697
First seen Mar 25, 2026 · Last updated Jun 17, 2026 · Updated 14 times
Summary
This study tests whether a combination of a controlled diet, structured exercise, and a supplement (symbiotic) can reduce harmful toxins and inflammation in young people with early chronic kidney disease (stages 1-3). Researchers will compare the effects of this 180-day program against standard care plus a placebo in 200 participants. The goal is to see if this approach can slow disease progression and improve kidney health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXERCISE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Instituto de Atención Integral de Enfermedades Renales del Estado de Aguascalientes
Aguascalientes, Aguascalientes, 20180, Mexico
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.